NYSE:GKOSMedical Equipment
Glaukos (GKOS) Q1 Loss Of US$0.34 EPS Reinforces Bearish Profitability Narrative
Glaukos (GKOS) has opened Q1 2026 with revenue of US$150.6 million and a basic EPS loss of US$0.34, while trailing twelve month revenue sits at US$551.3 million against a net loss of US$189.3 million. Over the past five reported quarters, revenue has moved from US$106.7 million in Q1 2025 to US$150.6 million in Q1 2026, as quarterly EPS losses ranged between US$0.28 and US$2.32. This keeps the spotlight firmly on how quickly the business can turn top line momentum into healthier margins.
See...